Community Pharmacy Medication Therapy Management for Heart Failure

Status unconfirmed · Not applicable

Conditions studied: Heart Failure

In brief

Pharmacist-provided medication therapy management (MTM) services have been suggested as a way to improve heart failure (HF) outcomes and counter fragmented care. Nevertheless, broad implementation of MTM services, especially for HF, has not occurred. Therefore, the investigators propose a community engagement pilot study to evaluate the feasibility of 1) training of community pharmacists to perform MTM for HF patients by the University of Rhode Island (URI) Faculty and Brown University Physicians, 2) community pharmacists performing MTM post-training for patients discharged with HF in their own community, 3) establishment of a community based research network (CBRN) and registry to assess the efficacy of the training and the MTM intervention through collaboration among patients with HF, community pharmacists and URI pharmacists and Brown University physicians.

Key facts

Study ID

NCT03608085

Run by

Providence VA Medical Center

People needed

83

Starts

2018-05-23

Expected to finish

2023-01-01

Last updated by the study team

2021-10-11

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• All licensed pharmacists aged ≥18 years that are employed at least part time (minimum of 4 hours per week) in a community pharmacy located in either Newport or Bristol Counties.
• All licensed pharmacists who anticipate working in a community pharmacy located in either Newport or Bristol Counties for the next 6 months
• Able to sign informed consent
• The State of Rhode Island pharmacy licensure requirements are as follows:
• Completion of a first professional degree program in pharmacy located within the United States and accredited by the American Council on Pharmaceutical Education.
• Completion of 1,500 internship hours.
• Passage of the North American Pharmacist Licensure Examination (NAPLEX), administered through the National Association of Boards of Pharmacy.
• Passage of the Multistate Pharmacy Jurisprudence Examination (MPJE) for Rhode Island, administered through the National Association of Boards of Pharmacy.

You may not qualify if…

• Pharmacists with an expired, inactive, suspended license.
• Pharmacist who, in the investigator's opinion, will not comply with study procedures or are unable to provide informed consent.
• Of note, we will not exclude pharmacists who have already completed the general National APhA certification program as this training intervention will focus on MTM in patients with HF
• Patient Participants
• Thirty patients aged >18 years discharged from Newport Hospital for a HF hospitalization who are prescribed at least 1 cardiovascular medication for HF and at least 3 other medications for chronic disease
• Inclusion Criteria
• All subjects >18 years old,
• ≤30 days post-HF hospitalization discharged to a community dwelling,
• Prescribed at least 1 cardiovascular medication for HF (ACE-Inbitors, Angiotensin Receptor Blockers, sacubitril, aldosterone antagonist, diuretics, digoxin, ivabradine and hydralazine, beta blockers and nitrates), and 3 other medications for chronic disease
• Able to sign consent and participate in a MTM consultation
• Exclusion Criteria
• Psychiatric instability (acutely suicidal, psychotic) or organic brain injury that precludes self-reporting on health status,
• Discharged to hospice or nursing home or assisted living facilities, or patients with a code status of comfort-measures-only
• Recipients of heart transplant, ventricular assist devices, intravenous inotropic infusions or woman who are pregnant since these conditions would preclude them from standard HF care.

Where it is running

• Ocean State Research Institute — Providence, Rhode Island, United States (enrolling)
• Providence VAMC — Providence, Rhode Island, United States (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.